Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis

Alex Castañeda-Sabogal, View ORCID ProfileDiego Chambergo-Michilot, View ORCID ProfileCarlos J. Toro-Huamanchumo, View ORCID ProfileChristian Silva-Rengifo, View ORCID ProfileJosé Gonzales-Zamora, View ORCID ProfileJoshuan J. Barboza
doi: https://doi.org/10.1101/2021.01.26.21250420
Alex Castañeda-Sabogal
1Universidad Privada Antenor Orrego, Facultad de Medicina, Escuela de Posgrado, Trujillo, Perú
2Universidad Privada Antenor Orrego, Facultad de Medicina, Trujillo, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego Chambergo-Michilot
3Universidad Científica del Sur, Lima, Perú
4Red Latinoamericana de Cardiología, Lima, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diego Chambergo-Michilot
Carlos J. Toro-Huamanchumo
5Universidad San Ignacio de Loyola, Unidad para la Generación y Síntesis de Evidencias en Salud
6Clínica Avendaño, Unidad de Investigación Multidisciplinaria, Lima, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos J. Toro-Huamanchumo
Christian Silva-Rengifo
2Universidad Privada Antenor Orrego, Facultad de Medicina, Trujillo, Perú
9Tau-Relaped Group, Trujillo, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian Silva-Rengifo
José Gonzales-Zamora
7University of Miami, Miller School of Medicine, Miami, Florida, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José Gonzales-Zamora
Joshuan J. Barboza
8Universidad Señor de Sipán, Escuela de Medicina, Chiclayo, Perú
9Tau-Relaped Group, Trujillo, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshuan J. Barboza
  • For correspondence: jbarbozameca@relaped.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background To assess the outcomes of ivermectin in ambulatory and hospitalized patients with COVID-19.

Methods Five databases and websites for preprints were searched until January 2021 for randomized controlled trials (RCTs) and retrospective cohorts assessing ivermectin versus control in ambulatory and hospitalized participants. The primary outcome was overall mortality. Secondary outcome was recovered patients. For meta-analysis, random-effects and inverse variance meta-analyses with logarithmic transformation were performed. ROBINS-I for cohort studies, and the Cochrane Risk of Bias 2.0 tool for trials were used. The strength of evidence was assessed using GRADE.

Results After the selection, twelve studies (five retrospective cohort studies, six randomized clinical trials and one case series), were included. In total, 7412 participants were reported, the mean age was 47.5 (SD 9.5) years, and 4283 (58%) were male. Ivermectin was not associated with reduced mortality (logRR: 0.89, 95% CI 0.09 to 1.70, p = 0.04, I2= 84.7%), or reduced patient recovery (logRR 5.52, 95% CI -24.36 to 35.4, p = 0.51, I2 = 92.6%). All studies had a high risk of bias, and showed a very low certainty of the evidence.

Conclusions There insufficient certainty and quality of evidence to recommend the use of ivermectin to prevent or treat ambulatory or hospitalized patients with COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors declare that they have no conflicts of interest. This study has not been funded by any institution.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was a systematic review, so no ethics committee review was required for approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Statement of financial support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

  • Disclosure statement: Authors declare that they have no conflict of interest.

Data Availability

All database access data for the systematic search are available in our supplementary material.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 27, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis
Alex Castañeda-Sabogal, Diego Chambergo-Michilot, Carlos J. Toro-Huamanchumo, Christian Silva-Rengifo, José Gonzales-Zamora, Joshuan J. Barboza
medRxiv 2021.01.26.21250420; doi: https://doi.org/10.1101/2021.01.26.21250420
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis
Alex Castañeda-Sabogal, Diego Chambergo-Michilot, Carlos J. Toro-Huamanchumo, Christian Silva-Rengifo, José Gonzales-Zamora, Joshuan J. Barboza
medRxiv 2021.01.26.21250420; doi: https://doi.org/10.1101/2021.01.26.21250420

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1746)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (651)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2930)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (741)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12495)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (319)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2626)
  • Public and Global Health (5336)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)